Acumen Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $54.0M | $35.6M | $66.9M | $130.1M | $122.2M | $43.8M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $122.3M | $178.3M | $246.6M | $180.3M | $198.7M | $44.4M |
| Property, Plant & Equipment | $103.0K | $73.0K | $122.0K | $165.0K | $36.0K | — |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $122.8M | $239.0M | $310.1M | $196.6M | $230.3M | $44.4M |
| Liabilities | ||||||
| Accounts Payable | $554.0K | $5.6M | $1.4M | $1.6M | $1.1M | $531.0K |
| Total Current Liabilities | $30.0M | $27.6M | $13.0M | $7.8M | $5.1M | — |
| Long-Term Debt | $22.4M | $29.4M | $29.9M | $0 | — | — |
| Total Liabilities | $52.4M | $57.2M | $43.2M | $7.8M | $5.1M | $6.4M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-446.5M | $-325.1M | $-222.8M | $-170.4M | $-127.6M | $-27.0M |
| Total Stockholders' Equity | $70.4M | $181.8M | $267.0M | $188.8M | $225.2M | $-18.6M |